Trademark: 97034358
Word
WUXI XDC THE BIOCONJUGATION LEADER
Status
Dead
Status Code
606
Status Date
Monday, June 10, 2024
Serial Number
97034358
Mark Type
3
Filing Date
Saturday, September 18, 2021
Published for Opposition
Tuesday, September 13, 2022
Abandoned Date
Monday, June 10, 2024

Trademark Owner History
WuXi XDC Cayman Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes in the nature of bioconjugate preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions, namely, antibody-drug conjugates in the nature of medical diagnostic reagents; pharmaceutical preparations, namely, drug conjugates consisting primarily of pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease
The mark consists of the stylized wordings "WUXI" over "XDC", partially inside an incomplete oval outline that intersects with another incomplete oval outline. Below these appears the wording "THE BIOCONJUGATION LEADER" in stylized font.
"WUXI" OR "BIOCONJUGATION"

Trademark Events
Oct 23, 2021
Notice Of Design Search Code E-Mailed
Sep 22, 2021
New Application Entered
Oct 22, 2021
New Application Office Supplied Data Entered
Jun 22, 2022
Assigned To Examiner
Jun 28, 2022
Examiners Amendment -Written
Jun 28, 2022
Examiners Amendment E-Mailed
Jun 28, 2022
Notification Of Examiners Amendment E-Mailed
Jun 28, 2022
Examiner's Amendment Entered
Sep 13, 2022
Published For Opposition
Aug 9, 2022
Approved For Pub - Principal Register
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Noa E-Mailed - Sou Required From Applicant
May 5, 2023
Sou Teas Extension Received
May 5, 2023
Teas Request To Divide Received
May 5, 2023
Divisional Request Received
May 5, 2023
Sou Extension 1 Filed
May 30, 2023
Case Assigned To Intent To Use Paralegal
Jun 1, 2023
Divisional Processing Complete
Jun 1, 2023
Sou Extension 1 Granted
Jun 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 2, 2023
Corrected Noa E-Mailed
Oct 26, 2023
Sou Teas Extension Received
Oct 26, 2023
Sou Extension 2 Filed
Oct 26, 2023
Sou Extension 2 Granted
Oct 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 10, 2024
Abandonment - No Use Statement Filed
Jul 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed

Trademark Alertz updated from USPTO on 2030-01-24